AIDS Treatment News Index, 2003

Abacavir+tenofovir+3TC failure                         393

Abbott raises Norvir price five fold                     397

Access for all, Thailand conference theme          395

ADAP organizing                                              388

ADAP Washington trip                                     397

Aegis                                                               388

Africa Action                                                   390

Africa trials -- no drugs                                     391

African-Americans and AIDS Conference         388

African-Americans and AIDS Conference         397

AIDS Treatment News online publication            397

AIDS Treatment News                                      396

Antibiotic-resistant staph                                    388

Atazanavir (Reyataz) approvee                          392

Bahamas antiretroviral prices, Clinton                 389

Biomedical research cuts                                   392

Bush AIDS initiative                                          388

Bush AIDS initiative                                          391

Buyers' club lists                                               397

Cholesterol management                                    394

Ciasullo, Eric, on returning to work                     395

Clinical Care Options for Hepatitis                      391

Clinical Care Options                                         388

Clinton Foundation lowers Caribbean price          389

Clinton Foundation, HAART 40 cents/day           395

Cohen, Dr. Cal, on Retroviruses conf., pt 1         389

Cohen, Dr. Cal, on Retroviruses conf., pt 2         390

Co-trimoxazole for staph                                    388

Counterfeit Procrit                                             389

Deep salvage                                                    390

Drug development                                             397

Efavirenz vs. nevirapine                                     389

Emtriva (FTC) approved                                    393

Export problem, WTO                                       394

Federal policy problems                                     392

Fosamprenavir approved                                    395

FTC (Emtriva) approved                                    393

Fundraising, online                                             392

FUZEON (T-20)                                               389

Glaxo research grants                                        391

Global Fund to FightAIDS, TB, and Malaria        388

Grassroots organizing                                         388

Heart disease guidelines                                     394

Highly experienced patients                                390

HIV Insite                                                        388

HIV nutrition info for doctors                             391

HIV treatment guidelines, July                            393

HIV treatment guidelines, November 2003          396

HIVandHepatitis.com                                        388

Hoffmann-La Roche, T-20                                 389

Huge price variations in generics                        391

IAS conference reports on Web                         393

International AIDS Society conf., Paris               392

Lexiva (908, Fosamprenavir)                              389

Lexiva approved                                                395

Medicaid cuts planned                                       390

Medicaid organizing                                           388

Medscape                                                         388

Microbicides                                                     391

MRSA                                                              388

NATAP                                                           388

Nelson Mandela on HIV treatment acess            393

Neuropathy treatment, new guidelines                 396

Nevirapine reduced maternal transmission           394

Nevirapine toxicity                                             389

Nevirapine vs. efavirenz                                    389

Norvir price fivefold rise                                    397

Paris conference reports on Web                       393

Pediatric HIV guidelines, November2003            396

Pharmaceutical company lobbying facts              397

Pharmacy benefits managers, profit                    391

Philadelphia FIGHT                                           391

Planetwork conference                                      392

Pneumocystis still cause of death in U.S.            391

Prevention policy problems                                 392

Prices of drugs                                                  391

Prison Health News                                          390

Prison skin infections                                         388

Retroviruses conference, Web coverage             388

Returning to work after disability                        395

Reyataz approved                                              392

Safety net failure                                               391

SARS Web information                                     390

Save ADAP committee                                     397

Search for a Cure, clinical trials forum                395

Social network software, for fundraising